Biological Intellectual Property Protection Act of 2025
Summary
HR6624 forces a structural onshoring of U.S. synthetic biology IP and manufacturing away from PRC entities. Domestic pure-plays Ginkgo Bioworks ($DNA) and Twist Bioscience ($TWST) are direct beneficiaries, while large biopharma Amgen ($AMGN) and Regeneron ($REGN) face near-term capex pressure but reduced long-term IP risk. The bill advanced out of committee with bipartisan support and has an identical Senate companion bill, increasing passage probability.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR6624 forces onshoring of synthetic biology IP and manufacturing away from PRC entities; no direct spending, but massive supply chain restructuring
- 2.Domestic pure-plays $DNA (Ginkgo Bioworks) and $TWST (Twist Bioscience) are direct structural beneficiaries
- 3.Large biopharma $AMGN and $REGN face near-term capex pressure but gain long-term IP protection; neutral with downside risk on execution
- 4.Bipartisan support and a Senate companion bill increase passage probability; floor vote likely within weeks
Market Implications
The bill is a catalyst for the U.S. synthetic biology sector. $DNA at $8.07 with a 30-day gain of 31.48% has already priced in partial expectation, but full passage could drive further multiple expansion as order volume from redirected biopharma spending materializes. $AMGN at $348.89 and $REGN at $706.58 are pricing in the capex headwind—watch for floor action as a binary event that could widen the spread between pure-plays and diversified biopharma. For retail investors, the clearest play is $DNA as a high-conviction beneficiary with direct revenue impact from onshoring orders.
⚡ Government Convergence
Active government convergence in this signal’s sector right now.
Over the last 90 days, 37 separate government actions have converged on Semiconductors / Onshoring. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 12 bills, 12 patents, 8 procurement notices, 2 executive actions, 1 insider buys, 1 congressional trades and 1 federal contracts — it's the clearest early tell that Washington is committing to semiconductors / onshoring, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBuilding Chips in America Act of 2023 · 2024-10-02
- BillTaiwan Allies Fund Act · 2025-04-01
- BillRemote Access Security Act · 2026-01-13
- Congressional tradeCleo Fields bought TSM ($1,001 - $15,000) · 2026-02-03
- BillFederal Acquisition Security Council Improvement Act of 2026 · 2026-02-04
- BillTo amend the Export Control Reform Act of 2018 to provide for expedited consideration of proposals for additions to, removals from, or other modifications with respect to entities on the Entity List, and for other purposes. · 2026-04-22
- BillSTRIDE Act · 2026-04-22
- Procurement noticeLethal Innovation Foundry Technologies (LIFT) Program · 2026-05-04
- Procurement noticeSources Sought Low Temp Anodic Bonding Glass Wafers · 2026-05-18
- Procurement noticeSources Sought Notice for a Close Fixture for Suss Wafer Bonder · 2026-06-26
- ContractSOUTHWEST RESEARCH INSTITUTE: TAS::80 0120::TAS AS THE PRINCIPAL INVESTIGATOR (PI) INSTITUTION FOR THE MAGNETOSPHERIC MULTISCALE (MMS) INSTRUMENT SUITE SCIENCE TEAM (ISS · 2026-07-01
- Executive actionProclamation: Further Strengthening Actions Taken to Adjust Imports of Aluminum into the United States · 2026-07-20
- Insider buyInsider buy: TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD ($301,350) · 2026-07-23
- Executive actionProclamation: Adjusting Imports of Polysilicon and its Derivatives into the United States · 2026-08-06
Full Analysis
On April 22, 2026, the House Foreign Affairs Committee ordered HR6624, the Biological Intellectual Property Protection Act of 2025, reported out on a 30-14 vote. The bill, sponsored by Rep. Davidson (R-OH) with 11 cosponsors including both Republicans and Democrats, restricts export of U.S. synthetic biology intellectual property and sensitive information to PRC entities. It now awaits a floor vote in the House. An identical companion bill, S3452, has been introduced in the Senate, signaling bipartisan coalition building.
The bill is an authorization bill—it sets policy and trade restrictions but does not appropriate funding. The mechanism is an export control: it prohibits transfer of synthetic biology IP and sensitive data to PRC-linked entities. There is no direct government spending allocation; the economic impact comes from forced restructuring of private sector supply chains.
Structural winners are domestic synthetic biology pure-play companies. Ginkgo Bioworks ($DNA) at $8.07 has rallied 31.48% in the last 30 days, reflecting market anticipation of this shift. Twist Bioscience ($TWST), though not provided in the market data here, is similarly positioned as a U.S.-based DNA synthesis leader. Both companies gain strategic value as compliant domestic alternatives to PRC-based CDMOs.
Structural laggards are large biopharma companies with PRC-linked manufacturing or R&D partnerships. Amgen ($AMGN) at $348.89 (30-day -0.84%) and Regeneron ($REGN) at $706.58 (30-day -8.55%) face near-term capital expenditure pressure to onshore or nearshore production. However, both benefit from reduced IP theft risk and supply chain security long-term, which supports earnings stability.
Legislative timeline: the bill must pass the full House, then the Senate (where identical S3452 awaits committee action), then be signed by the President. Given bipartisan support and a committee vote with only 14 nays, passage probability is elevated but not guaranteed. Floor action could occur within weeks.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Some confirming evidence found across public data sources
What the bill does
Export restriction on U.S. synthetic biology IP and sensitive information to PRC entities; creates structural barrier to PRC-based CDMO partnerships
Who must act
U.S. biopharma companies and CDMOs currently sourcing synthetic biology services or transferring IP to PRC-linked entities
What happens
U.S. biopharma must onshore or nearshore synthetic biology R&D and production, increasing demand for domestic pure-play platform providers
Stock impact
Ginkgo Bioworks ($DNA) is a U.S.-based synthetic biology pure-play with cell programming platform revenue; immediate strategic value as a compliant, domestic alternative to PRC-based CDMOs. 30-day +31.48% price momentum reflects market pricing in this demand shift.
What the bill does
Export restriction on U.S. synthetic biology IP and sensitive information to PRC entities; restricts DNA synthesis and gene-editing service transfers
Who must act
U.S. biopharma and research institutions using PRC-based gene synthesis or DNA manufacturing services
What happens
Shift of DNA synthesis orders to U.S.-based providers, increasing domestic order volume and pricing power
Stock impact
Twist Bioscience ($TWST) is a U.S. pure-play DNA synthesis provider with Silicon Valley manufacturing; directly captures orders redirected from PRC competitors. Not provided in real market data, but structurally positioned as beneficiary.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Proclamation: Adjusting Imports of Polysilicon and its Derivatives into the United States
Proclamation: Further Strengthening Actions Taken to Adjust Imports of Aluminum into the United States
Stop Stealing our Chips Act
A bill to amend the Export Control Reform Act of 2018 to provide for the security of information and communications technology and services supply chains, and for other purposes.
To amend the Arms Export Control Act to modify a limitation relating to export and transfers of defense articles and services under the AUKUS partnership, and for other purposes.
A bill to establish a grant program for education related to semiconductor manufacturing and related industries.
To amend the Internal Revenue Code of 1986 to incentivize the domestic production and use of permanent magnets, and for other purposes.
A bill to enhance the administration of export control licenses under the Export Control Reform Act of 2018, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Adjusting Imports of Polysilicon and its Derivatives into the United States
This proclamation invokes Section 232 of the Trade Expansion Act to impose a minimum import price (MIP) program on polysilicon and its derivatives, a 15% ad valorem tariff on polysilicon derivatives, and directs the Secretary of Commerce to offer incentives for domestic production. It aims to protect and revive the U.S. polysilicon industry by restricting imports that threaten national security, particularly for semiconductor and solar supply chains.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →